Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127555452 | 12755545 | 2 | F | 20160630 | 20160907 | 20160916 | 20160921 | EXP | IT-PFIZER INC-2016419874 | PFIZER | 73.00 | YR | Y | 55.00000 | KG | 20160921 | PH | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127555452 | 12755545 | 1 | PS | GEMCITABINE HYDROCHLORIDE. | GEMCITABINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 1100 MG, CYCLIC | Y | 200795 | 1100 | MG | SOLUTION FOR INJECTION | ||||||
| 127555452 | 12755545 | 2 | SS | ABRAXANE | PACLITAXEL | 1 | 130 MG, CYCLIC | Y | 0 | 130 | MG | ||||||||
| 127555452 | 12755545 | 3 | C | ENAPREN | ENALAPRIL MALEATE | 1 | Oral | 10 MG, UNK | 0 | 10 | MG | TABLET | |||||||
| 127555452 | 12755545 | 4 | C | LASIX | FUROSEMIDE | 1 | Oral | 50 MG, UNK | 0 | 50 | MG | TABLET | |||||||
| 127555452 | 12755545 | 5 | C | ZYLORIC | ALLOPURINOL | 1 | Oral | 300 MG, UNK | 0 | 300 | MG | TABLET | |||||||
| 127555452 | 12755545 | 6 | C | CLEXANE | ENOXAPARIN SODIUM | 1 | Subcutaneous | 8000 IU, UNK | 0 | 8000 | IU | SOLUTION FOR INJECTION | |||||||
| 127555452 | 12755545 | 7 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 100 MG, UNK | 0 | 100 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127555452 | 12755545 | 1 | Pancreatic carcinoma |
| 127555452 | 12755545 | 2 | Pancreatic carcinoma |
| 127555452 | 12755545 | 3 | Hypertension |
| 127555452 | 12755545 | 4 | Hypertension |
| 127555452 | 12755545 | 5 | Hyperuricaemia |
| 127555452 | 12755545 | 6 | Thrombosis prophylaxis |
| 127555452 | 12755545 | 7 | Ischaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127555452 | 12755545 | OT |
| 127555452 | 12755545 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127555452 | 12755545 | Anaemia | |
| 127555452 | 12755545 | Cardiac failure | |
| 127555452 | 12755545 | Dyspnoea | |
| 127555452 | 12755545 | Erythema | |
| 127555452 | 12755545 | Pruritus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127555452 | 12755545 | 1 | 20160609 | 20160831 | 0 | |
| 127555452 | 12755545 | 2 | 20160609 | 20160831 | 0 |